The general shift from acute infectious and deficiency diseases characteristic of underdevelopment to chronic non-communicable diseases characteristic of modernization and advanced levels of development is usually referred to as the "epidemiological transition".
Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, replicable approach, as well as a comprehensive update on fertility. GBD 2017 incorporates major data additions and improvements, using a total of 68,781 data sources in the estimation process.
The general shift from acute infectious and deficiency diseases characteristic of underdevelopment to chronic non-communicable diseases characteristic of modernization and advanced levels of development is usually referred to as the "epidemiological transition".
Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, replicable approach, as well as a comprehensive update on fertility. GBD 2017 incorporates major data additions and improvements, using a total of 68,781 data sources in the estimation process.
The Burden of Disease ( BOD) analysis describes in details the uses and effects of BOD. How to measure it. Special emphasis has been given in understanding HALY, DALY and QALY.
N.B: 1. Please download the ppt first, as the animations will act better then
2. There are few hidden slides in the presentation, which you may explore too.
mortality indicator, IMR, MMR, disease-specific mortality, uses of mortality data, morbidity indicator, disability rates, nutritional status indicators, health care delivery indicators, utilization rates, social health indicators, mental health indicators, environmental indicators, socio-economic indicators, health policy indicators, indicators of quality of life, other indicators
Understanding the concept of Universal Health Coverage (UHC) and how can we reach it, both globally and also in India. The presentation also includes HLEG report , which is the proposed architecture for India's guide to reach UHC.
As per John M. Last (1988) Epidemiology is the study of the distribution and determinants of health related states or events in specified populations, and the application of this study to the control of health problems.
Universal health coverage (UHC) means that all people and communities can use the promotive, preventive, curative, rehabilitative and palliative health services they need, of sufficient quality to be effective, while also ensuring that the use of these services does not expose the user to financial hardship.
Chapter TwoHealth Determinants, Measurements, and Trends.docxtiffanyd4
Chapter Two
Health Determinants, Measurements, and Trends
Overview
What are the determinants of health?
What are the most important health indicators and key terms related to measuring health status and the burden of disease?
What are the leading causes of death and the burden of disease in low-, middle-, and high-income countries?
What are the demographic and epidemiological transitions?
The Importance of Measuring Health Status
In order to address global health issues, we must understand:
The factors that influence health status most
The indicators used to measure health status
The key trends in health status that have occurred historically
Determinants of Health
The interconnected factors that determine an individual’s health status
Determinants include personal and inborn features, socioeconomic status, culture, environment, educational attainment, health behaviors, childhood development, access to care, and government policy
Increasing attention is being paid to the social determinants of health
Key Health Indicators
Health status indicators are useful for:
Finding which diseases people suffer from
Determining the extent to which the disease causes death or disability
Carrying out disease surveillance
To perform these functions, it is important to use a consistent set of indicators in order to make comparisons
Key Health Indicators
Key Health Indicators
Key Health Indicators
Key Health Indicators
Key Health Indicators
Key Health Indicators
Key Health Indicators
Terms
Morbidity—sickness or any departure, subjective or objective, from a psychological or physiological state of well-being
Mortality—death
Disability—temporary or long-term reduction in a person’s capacity to function
13
Key Health Indicators
Terms
Prevalence—number of people suffering from a certain health condition over a specified period
Incidence—the rate at which new cases of a disease occur in a population
14
Key Health Indicators
Communicable diseases—illnesses caused by a particular infectious agent that spreads directly or indirectly from people to people, animals to people, or people to animals; also called infectious diseases
Noncommunicable diseases—illnesses not spread by an infectious agent
Injuries—include road traffic injuries, falls, self-inflicted injuries, and violence, among other things
Vital Registration
Vital registration systems record births, deaths, and causes of death
An accurate system is key to having quality data on a population
Many low- and middle-income countries lack a vital registration system
Often there are cultural barriers to timely vital registration
Vital Registration
Measuring the Burden of Disease
Health-Adjusted Life Expectancy (HALE)
Summarizes expected number of years to be lived in what might be termed the equivalent of good health
A health-expectancy measure
To calculate HALE: the years of ill health are weighted according to severity and subtracted from overall life e.
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...Sherbrooke Innopole
By: Pierre-Carl Michaud, Industrial Alliance Research Chair on the Economics of Demographic Change
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
The Burden of Disease ( BOD) analysis describes in details the uses and effects of BOD. How to measure it. Special emphasis has been given in understanding HALY, DALY and QALY.
N.B: 1. Please download the ppt first, as the animations will act better then
2. There are few hidden slides in the presentation, which you may explore too.
mortality indicator, IMR, MMR, disease-specific mortality, uses of mortality data, morbidity indicator, disability rates, nutritional status indicators, health care delivery indicators, utilization rates, social health indicators, mental health indicators, environmental indicators, socio-economic indicators, health policy indicators, indicators of quality of life, other indicators
Understanding the concept of Universal Health Coverage (UHC) and how can we reach it, both globally and also in India. The presentation also includes HLEG report , which is the proposed architecture for India's guide to reach UHC.
As per John M. Last (1988) Epidemiology is the study of the distribution and determinants of health related states or events in specified populations, and the application of this study to the control of health problems.
Universal health coverage (UHC) means that all people and communities can use the promotive, preventive, curative, rehabilitative and palliative health services they need, of sufficient quality to be effective, while also ensuring that the use of these services does not expose the user to financial hardship.
Chapter TwoHealth Determinants, Measurements, and Trends.docxtiffanyd4
Chapter Two
Health Determinants, Measurements, and Trends
Overview
What are the determinants of health?
What are the most important health indicators and key terms related to measuring health status and the burden of disease?
What are the leading causes of death and the burden of disease in low-, middle-, and high-income countries?
What are the demographic and epidemiological transitions?
The Importance of Measuring Health Status
In order to address global health issues, we must understand:
The factors that influence health status most
The indicators used to measure health status
The key trends in health status that have occurred historically
Determinants of Health
The interconnected factors that determine an individual’s health status
Determinants include personal and inborn features, socioeconomic status, culture, environment, educational attainment, health behaviors, childhood development, access to care, and government policy
Increasing attention is being paid to the social determinants of health
Key Health Indicators
Health status indicators are useful for:
Finding which diseases people suffer from
Determining the extent to which the disease causes death or disability
Carrying out disease surveillance
To perform these functions, it is important to use a consistent set of indicators in order to make comparisons
Key Health Indicators
Key Health Indicators
Key Health Indicators
Key Health Indicators
Key Health Indicators
Key Health Indicators
Key Health Indicators
Terms
Morbidity—sickness or any departure, subjective or objective, from a psychological or physiological state of well-being
Mortality—death
Disability—temporary or long-term reduction in a person’s capacity to function
13
Key Health Indicators
Terms
Prevalence—number of people suffering from a certain health condition over a specified period
Incidence—the rate at which new cases of a disease occur in a population
14
Key Health Indicators
Communicable diseases—illnesses caused by a particular infectious agent that spreads directly or indirectly from people to people, animals to people, or people to animals; also called infectious diseases
Noncommunicable diseases—illnesses not spread by an infectious agent
Injuries—include road traffic injuries, falls, self-inflicted injuries, and violence, among other things
Vital Registration
Vital registration systems record births, deaths, and causes of death
An accurate system is key to having quality data on a population
Many low- and middle-income countries lack a vital registration system
Often there are cultural barriers to timely vital registration
Vital Registration
Measuring the Burden of Disease
Health-Adjusted Life Expectancy (HALE)
Summarizes expected number of years to be lived in what might be termed the equivalent of good health
A health-expectancy measure
To calculate HALE: the years of ill health are weighted according to severity and subtracted from overall life e.
SILS 2015 - Future Longevity and Population Health Improvements: An Economic ...Sherbrooke Innopole
By: Pierre-Carl Michaud, Industrial Alliance Research Chair on the Economics of Demographic Change
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
Mmmmm
13 Teams
__
Average talent teams that get along well with each other are more productive than gifted teams that don’t get along. It doesn’t matter how well a team with low emotional intelligence is in control of the numbers. They can’t even decide what to try to do.
14 Stress
___
Difficulties at work and in our relationships put us under stress. Stress makes it difficult for us to find solutions to problems. When we can’t find solutions to problems, we get more stressed. To get rid of this dead end, we need to know how to manage our stressful situations.
15 Marriage
____
The secret of long and happy marriages is sincerity in your feelings. If your marriage was not built on this basis of intimacy from the very beginning, it will begin to crack over the years. Even small problems become unsolvable. You have to be emotionally open at the beginning of the road.
16 Leadership
______
Leadership does not mean dominance. Leading your colleagues to a common goal and making them believe in the reality of this purpose. Successful leaders are those who can keep their team’s motivation alive for many years. You have to make them desire the work to be done.
17. Emotions Are All Normal
___
Anger, hatred, love, happiness… You can understand when and under what circumstances these feelings will emerge by following yourself. You may have these feelings depending on how you interpret the events you encounter. The important thing is to be able to react independently of your feelings. You may find yourself making promises that you cannot keep because you are happy, or you may resort to violence when you are angry.
18/ Being able to Express Your Emotions
____
Not everyone’s level of empathy can be very good. You may be in a difficult situation immediately. You may feel bad, but people may not understand it. In these situations, you may need to express your feelings a little more directly.
19/You Are Not Your Emotions
______
Keep doing what you need to do, no matter how you feel. Success is achieved by people who cannot give up no matter what their feelings and thoughts are. Don’t let your feelings affect your actions.
20/ Timing
__
As soon as you feel a different emotion, try to think before you act. Because emotional intelligence moves faster than rational intelligence, it can make you act irrationally and make you say any unnecessary words.
Thanks for reading
~ 𝗧𝗼𝗻𝗴𝘀𝗮 𝗚𝘂𝘆
Book:- https://amzn.to/3XsVTz2.
13 Teams
__
Average talent teams that get along well with each other are more productive than gifted teams that don’t get along. It doesn’t matter how well a team with low emotional intelligence is in control of the numbers. They can’t even decide what to try to do.
14 Stress
___
Difficulties at work and in our relationships put us under stress. Stress makes it difficult for us to find solutions to problems. When we can’t find solutions to problems, we get more stressed. To get rid of this dead end, we need to know how to manage our stress
Jean Bousquet: Healthy Ageing as an Opportunity for Planetary HealthTHL
Jean Bousquet, Professor, University Hospital of Montpellier, France, at Europe That Protects - Safeguarding Our Planet, Safeguarding Our Health EU side event, 3-4 Dec 2019, THL, Helsinki
Social Determinants of Health: Why Should We Bother?Renzo Guinto
Presentation delivered during the 2nd Social Oncology Forum with the theme "Social Determinants of Health in Agricultural Communities." November 10, 2013, Benguet State University, La Trinidad, Benguet.
Presentation delivered by Dr Zsuzsanna Jakab, Regional Director WHO Europe, at the international health forum (Ashgabat, Turkmenistan, 21-22 July 2015)
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
Health transition
1. Course Faculty:
Mohammad Bellal Hossain
Associate Professor and Chairman
Presented By: Group 1
Group 1 Members:
1.WasekSazzad , ZH002
2.Shafayat Sultan , KJ010
3.TasmiahNuzhath, KM012
4.ZakiulAlam ,ZH013
5.TahminaAkter Happy, SM 017
6.SawkiaAfroz,KM019
Date: 18.01.2014
2. To find out the definition of health
transition
To find out the trend of
epidemiological(the shift from
communicable or infectious diseases
towards chronic diseases) and
demographic transition(e0 increase)
and the role of determinants
› Economic determinants
› Socio-cultural and political determinants
› Medical advancement and rise of public
health
3. The health transition relates to the role that the
cultural, social and behavioral determinants of health
play in rising life expectancy at birth (the mortality
transition) and the decreasing proportion of all
deaths caused by infectious diseases (the
epidemiological transition).
Historical overview,
The current factors that are relevant to the new
public health in infectious diseases have to be
considered within a historical context which has
taken place into different stages.
› 1. The age of Pestilence and Famine
› 2. The age of receding Pandemics
› 3. The age of degenerative and man-made diseases
7. The determinants of Health Transition can
be divided under three broad
categories:
1.Economic & Nutritional Determinants
2.Socio-Cultural & Political Determinants
3.Medical Advancement & Raise of
Public Health.
8. Economic & Nutritional Determinants
encompasses with the following factors:
1.Industrialization & Urbanization
2.Increase of per capita income/GDP
3.Level of RF(Rapid Fitness): Fat, calories,
tobacco, sedentary habits.
4.Nutrition Technology for Health Care
5. Increase of Standard of Living
6. Personal hygiene
7. Change in food intake pattern
9. Socio-Cultural & Political Determinants
comprises with:
1. Improvement of education
2. Behavior Change
3. Cultural Influence
4. Rise of Social Awareness
5. Rise of Community Support
10. There lies several factors under Medical
Advancement & Raise of Public Health,
these are:
1.Improvement of Medical Technology
2.Improvement of Health care facilities
3.Rise of Public Health
I. Purification of water
II. Improvement of Sanitation facilities